Skip to main content
. 2015 Jun 21;21(23):7305–7312. doi: 10.3748/wjg.v21.i23.7305

Table 4.

Adverse events n (%)

I: rSK schedule A II: rSK schedule B III: Hydrocortisone
n 170 170 170
Total subjects with adverse events 5 (2.9) 7 (4.1) 11 (6.5)
Events
Anal pruritus 2 (1.2) 4 (2.4) 2 (1.2)
Rectal bleeding 2 (1.2) 1 (0.6) 1 (0.6)
Anal fissure 1 (0.6) 0 3 (1.8)
Headache 1 (0.6) 2 (1.2) 0
Anal pain 0 0 2 (1.2)
Local burning sensation 1 (0.6) 0 1 (0.6)
Tenesmus 1 (0.6) 0 1 (0.6)
Constipation 0 0 1 (0.6)
Diarrhea 0 0 1 (0.6)
Discomfort due to mass sensation 1 (0.6) 0 0
Edema 0 0 1 (0.6)
Stroke 0 0 1 (0.6)

rSK: Recombinant streptokinase.